Carcinoma in situ of skin of other parts of face is a non-invasive malignancy characterized by abnormal growth of skin cells confined to the epidermis. It is primarily caused by prolonged sun exposure, genetic predisposition, or exposure to carcinogenic substances. Accurate coding with ICD-10 Code D04.39 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and treatment.
ICD-10 Code D04.39 represents Carcinoma in situ of skin of other parts of face, indicating a localized, non-invasive cancerous condition. This code is used when documenting cases where the carcinoma is confined to the skin without invasion into deeper tissues. It is crucial for accurate clinical documentation and billing, particularly in dermatology and oncology settings.
Carcinoma in situ of skin of other parts of face arises from the uncontrolled proliferation of keratinocytes, often due to UV radiation exposure. This condition requires medical attention to prevent progression to invasive cancer. Early detection and treatment are vital for favorable outcomes.
ICD-10 Code D04.39 is utilized in SOAP notes to document the diagnosis and management of Carcinoma in situ of skin of other parts of face. It aids in capturing patient symptoms, clinical assessments, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
In SOAP notes, ICD-10 Code D04.39 connects subjective patient reports and objective clinical findings to a formal diagnosis of Carcinoma in situ of skin of other parts of face. This coding ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Prompt treatment of Carcinoma in situ of skin of other parts of face is essential to prevent progression to invasive cancer. Treatment options vary based on the lesion's characteristics and patient factors.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D04.39 is critical in medical billing, particularly in dermatology and oncology settings, ensuring accurate claims processing.
| CPT Code | Description |
|---|---|
| 11100 | Biopsy of skin, excisional, for lesions. |
| 17000 | Destruction of benign lesions, first lesion. |
| 99213 | Established patient office visit, level 3. |
Common Questions About Using ICD-10 Code D04.39 for Carcinoma in situ of skin of other parts of face
What are the common symptoms of Carcinoma in situ of skin of other parts of face?
Common symptoms include a persistent red patch, scaly skin, or a non-healing sore on the face. Patients may not experience pain or itching, but cosmetic concerns often prompt evaluation.
How is Carcinoma in situ of skin of other parts of face treated?
Treatment options include cryotherapy, topical chemotherapy, or surgical excision, depending on the lesion's characteristics and patient factors. Regular follow-up is essential for monitoring.
Is Carcinoma in situ of skin of other parts of face contagious?
No, Carcinoma in situ is not contagious. It is a localized skin cancer that arises from abnormal cell growth and is not transmitted between individuals.
When should I seek medical attention for skin changes?
Patients should seek medical attention for any persistent skin changes, such as new growths, non-healing sores, or changes in existing moles, especially in sun-exposed areas.
Clinical Notes
SOAP notes
DAP notes
AI medical notes